Karen Ferrell Net Worth

Karen Ferrell biography

Karen E. Ferrell serves as Independent Director of the Company. Ms. Ferrell has served as a director of the Company since October 26, 2018. Ms. Ferrell has served as the Executive Chairman and Chief Executive Officer of Advantum Health, a tech-driven revenue cycle management company since January 2020. Prior to that, she served as the Executive Chairman and Chief Executive Officer at Glenridge HealthCare Solutions, a national tech-enabled network solutions company, from December 2015 to January 2020. From November 2014 to November 2015, Ms. Ferrell served as an independent healthcare consultant and advisor. She served as Chief Executive Officer of Zest Health, a digital consumer healthcare company, from September 2013 to October 2014. Ms. Ferrell served as President and Chief Executive Officer of Apollo Health Street, a healthcare solutions company, from May 2010 to March 2013. An involuntary bankruptcy petition was filed against Apollo Health Street in 2012; the petition was determined to be filed without merit and was subsequently dismissed. She served as Senior Vice President of Provider Contracting and Medical Management of CIGNA Healthcare, a worldwide health services organization, from November 2003 to March 2009. Ms. Ferrell served as a Senior Manager at Deloitte Consulting, a global consulting firm, from February 2000 to November 2003. Prior to this, Ms. Ferrell held leadership positions including President of Aetna Healthplans of Florida, Executive Director at Scripps Health and Vice President of Provider Contracting at Prudential HealthCare. Ms. Ferrell also serves as a director of CredSimple, a tech-enabled credentialing and network management company, and Advantum Health. Ms. Ferrell received an M.B.A. from Pepperdine University.

How old is Karen Ferrell?

Karen Ferrell is 62, she's been the Independent Director of VIVUS since 2018. There are 4 older and 5 younger executives at VIVUS. The oldest executive at VIVUS, Inc. is Edward Kangas, 75, who is the Independent Director.

What's Karen Ferrell's mailing address?

Karen's mailing address filed with the SEC is C/O VIVUS, INC., 900 E. HAMILTON AVE., SUITE 550, CAMPBELL,, CA, 95008.

Insiders trading at VIVUS

Over the last 21 years, insiders at VIVUS have traded over $6,261,269 worth of VIVUS stock and bought 5,180,746 units worth $13,074,554 . The most active insiders traders include Tide Capital, Llc North Tid..., Alexander J Denner, eErnest Mario. On average, VIVUS executives and independent directors trade stock every 39 days with the average trade being worth of $35,394. The most recent stock trade was executed by John P. Amos on 1 March 2019, trading 11,000 units of VVUS stock currently worth $53,350.

What does VIVUS do?

VIVUS, Inc. engages in the development and commercialization of novel therapeutic products. The firm's products are indicated for the treatment of obese and overweight patients, exocrine pancreatic insufficiency, and erectile dysfunction. Its products include PANCREAZE, Qsymia, and STENDRA/SPEDRA. The company was founded by Virgil A. Place in April 16, 1991 and is headquartered in Campbell, CA.

VIVUS executives and stock owners

VIVUS executives and other stock owners filed with the SEC include:

• John Amos,
  Chief Executive Officer, Director
• John Slebir,
  Senior Vice President - Business Development, General Counsel, Secretary
• Santosh Varghese,
  Senior Vice President, Chief Medical Officer
• Mark Oki,
  Chief Financial Officer, Senior Vice President, Chief Accounting Officer
• Thomas King,
  Independent Director
• David Norton,
  Independent Chairman of the Board
• Jill Frizzley,
  Independent Director
• Herman Rosenman,
  Independent Director
• Jorge Plutzky,
  Independent Director
• Edward Kangas,
  Independent Director
• Karen Ferrell,
  Independent Director
• Allan Shaw,
  Director
• Herm Rosenman,
  Director
• Eric W Roberts,
  Director
• Tide Capital, Llc North Tid...,
  
• Seth H. Z. Fischer,
  Chief Executive Officer
• Mayu Sris,
  Director
• Kenneth Suh,
  President
• Wesley Day,
  Vice President, Clinical
• Michael /Ny/ Miller,
  Chief Commercial Officer
• Wang Changjin,
  VP, Business Development
• Virgil A Place,
  Chairman & CSO
• Graham Strachan,
  Director
• Samuel F Colin,
  Director
• Ernest Mario,
  Director
• Anthony P. Zook,
  Chief Executive Officer
• John W Dietrich,
  Vice President, R & D
• Terry Nida,
  VP, Worldwide Marketing/
• Svai S Sanford,
  Interim CFO
• Mario M Rosati,
  Director
• Alexander J Denner,
  Director
• Jon C Biro,
  10% owner
• J Martin Carroll,
  Director
• Robert N Wilson,
  Director
• Alexander J Sarissa Capital...,
  
• M. Scott Oehrlein,
  Chief Operations Officer
• Timothy E Morris,
  VP, Finance and CFO
• Leland F Wilson,
  President & CEO
• Linda M Dairiki Shortliffe,
  Director
• Charles J Casamento,
  Director
• Lee Perry,
  Vice President & Chief
• Jacob Pieter Kastelein Joha...,
  Director
• Michael J Astrue,
  Director
• Mark B Logan,
  Director
• Michael Patrick Miller,
  SVP, Chief Commercial Officer
• Guy P Marsh,
  VP, Operations & General Mgr.
• Neil Gesundheit,
  VP, Chief Medical Officer
• Larry J Strauss,
  Vice President, Finance & CFO
• James R Nickel,
  Vice President, Clinical
• Peter Y Tam,
  VP, Business Planning
• Carol Zoltowski,
  Vice President, Regulatory
• Lori Forrest,
  VP, Operations & General Mgr.